Anticounterfeit packaging technologies

Journal of Advanced Pharmaceutical Technology and Research

Volumn 1, Issue 4, 2010, Pages 368-373

  Shah, Ruchir Y ^a   Prajapati, Prajesh N ^a   Agrawal, Y K ^a  

^a GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

Author keywords

Counterfeit drugs; covert; overt; packaging

Indexed keywords

ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; ANTIOBESITY AGENT; ANTIPROTOZOAL AGENT; CARDIOVASCULAR AGENT; HORMONE DERIVATIVE; SILDENAFIL; STEROID;

BIOMETRY; CODING; COUNTERFEITING; DRUG COATING; DRUG CONTROL; DRUG DOSAGE FORM; DRUG LEGISLATION; DRUG PACKAGING; DRUG QUALITY; DRUG STABILITY; ECONOMIC ASPECT; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE SYSTEM; HOLOGRAPHY; LEGAL ASPECT; NANOTECHNOLOGY; OUTCOME ASSESSMENT; PACKAGING MATERIAL; PATENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS TECHNOLOGY; RADIOFREQUENCY IDENTIFICATION; REVIEW; SEALED CONTAINER;

EID: 79952912388     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/0110-5558.76434     Document Type: Review

References (48)

1. Kusum D, Burande M, Jobanputra SB. Packaging solutions to the changing Pharma market needs. Pharma Times 2007;39:29-34.
2. Soroka. Fundamentals of Packaging Technology. Institute of Packaging Professionals 2002 ISBN 1-930268-25-4.
3. Sangal T, Shukla N. Generic drug industry in India. The counterfeit spin. J IPR 2009;14:136-240
4. White paper. Dhar R. Anti counterfeit packaging technologies. A strategic need for the Indian industry. Confederation of Indian Industry 2009:1-47. Available from: http://www.bilcare.com/pdf/CII-anti-counterfeit-pkg- technologies-report.pdf [last cited on 2010 Oct 29].
5. Olsmats C. The business mission of Packaging. Packaging as a strategic tool for business development towards the future. bo: bo Akademi University Press; 2002.
6. Cordell VV, Wongtada N, Kieschnick RL. Counterfeit purchase intentions: Role of lawfulness attitudes and product traits as determinants. J Bus Res 1996;35:41-53. (Pubitemid 126168359)
7. Phau I, Min T. Devil wears (Counterfeit) Prada. J Consum Mark 2009;26:15-27.
8. Counterfeit drugs. Guidelines to develop measures to combat counterfeit drugs. Department of essential drugs and other medicines. World Health Organization (WHO). 1999. Available from: http://www.whqlibdoc.who.int/hq/1999/ WHO-EDM-QSM-99.1.pdf [last cited on 2010 Jun 5].
9. Clark C. Pharmaceutical counterfeiting. Pharm J 2003;271:453.
10. Counterfeit medicines. Parliamentary office of science and technology (post note) 2010;352:1-4.
11. Zaichkowsky L. Brand imitation: Do the Chinese have different views. Asia Pac J Manage 1999;16:179-92.
12. Business Insights. Pharmaceutical anti counterfeiting strategies. Protecting profits through operational security, new technologies and industry partnerships. 2005. p. 43.
13. Swaminath G. Faking it-II: Countering and preventing counterfeiting of drugs. Indian J Psychiatry 2009;51:9-11.
14. Business Action to Stop Counterfeiting and Piracy (BASCAP). Research report on consumer attitudes and perceptions on counterfeiting and piracy 2009:1-105. Available from: http://www.iccwbo.org/bascap [last cited on 2010 Sep 10].
15. Zurich ET. SAP Research. Anti counterfeiting requirements report. Building radio frequency identification for the global environment (BRIDGE), 2007. p. 1-85.
16. Cockburn R. Death by Dilution. The American Prospect 2005. Available from: http://www.prospect.org/cs/articles [last cited on 2010 Sep 10].
17. BCC Research. Anti counterfeiting Packaging Technologies in the US Pharmaceutical and Food Industries 2007. Available from: www.bccresearch.com/ report/FOD042A.html [last cited on 2010 May 31].
18. Organization for Economic Cooperation and Development (OECD). The economic impact of counterfeiting 1998.
19. Organization for Economic Cooperation and Development (OECD). The economic impact of counterfeiting and piracy 2008.
20. Harvey B. Pharmaceutical counterfeiting: Issues, trends, measurement, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) President. Pharmaceutical Security Institute (PSI) WIPO/OECD Workshop 1992. Available from: http://www.oecd.org/dataoecd/42/30/35650404.pdf [last cited on 2010 May 31].
21. Woods K. Anti counterfeiting strategy. Medicines and healthcare products regulatory agency (MHRA) UK 2007-2010. p. 1-42.
22. Counterfeit medicines. QA counterfeit. World Health Organization (WHO) 2009. Available from: http://www.who.int/medicines/services/counterfeit/faqs/ QACounterfeit-october2009.pdf [last cited on 2010 Jun 12].
23. Glaxo Smith Kline. Government affairs, the counterfeiting of healthcare products, Global public policy issues, a publication of Europe and corporate 2009. Available from: http://www.gsk.com/../GSK-on-counterfeiting-of-healthcare- products.pdf [last cited 2010 May 25].
24. MacInnis W. The counterfeit report. Intellectual property crime investigator's newsletter. Royal Canadian Mounted Police Federal Enforcement Branch, 2006. p. 1-15.
25. Deisingh AK. Pharmaceutical counterfeiting. Tutorial Review. The Analyst. The Royal society of chemistry 2005;130:271-9. Available from: http://www.rsc.org/analyst [last cited on 2010 Sep 10].
26. Protecting consumer from counterfeit drugs. FDA consumer magazine, 2004. p. 38.
27. Ault A. FDA moves to curb drug counterfeiting. Lancet 2003. p. 362. Available from: http://www.thelancet.com [last cited on 2010 Sep 10].
28. American bank note holographics. Pharmaceutical Counterfeiting, Tampering and Diversion. The threat to world health and quest for solutions, 2002. p. 1-13.
29. ICC Commercial Crime Services 2003. Available from: http://www.iccwbo. org/ccs/news-archives/2003/counterfeit-drugs.asp [last cited on 2010 Jul 15].
30. Wondemagegnehu E. Pharmaceutical Counterfeiting: A WHO perspective in pharmaceutical fraud and counterfeiting. SMI conference documentation. London: SMI Publishing; 2003.
31. Available from: http://www.securingpharma.com [last cited on 2010 Sep 26].
32. Available from: http://www.safemedicines.org/[last cited on 2010 Oct 9].
33. An ICC initiative Business Action to Stop Counterfeiting and Piracy (BASCAP). Brand protection directory. The World Business Organization. Available from: http://www.iccwbo.org/bascap [last cited on 2010 Jun 10].
34. Jotcham R. Understanding and evaluating security technologies for pharmaceuticals, in combating Pharmaceutical fraud and counterfeiting. SMI conference documentation. London: SMI publishing; 2003.
35. Application White Paper. New pharmaceutical marking guidelines and opportunities, tips, techniques and technologies for implementing unit of use bar code, anti counterfeiting and RFID labeling to improve patient safety, satisfy new FDA rules and business partner requirements, 2004. p. 1-13.
36. Benbasat AY. A survey of current optical security techniques. Massachusetts: MIT Media Lab; 1999. p. 1-20.
37. Lancaster I. Anti counterfeiting holograms. Security technology 2009. p. 24-5. Available from: http://www.canadianprinter.com [last cited on 2010 Sep 10].
38. Newton PN, Green MD, Fernandez FM, White NJ. Counterfeit anti-infective drugs. Lancet 2006;6:602-13. Available from: http://www.infection.thelancet.com [last cited on 2010 Sep 10].
39. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, et al. Manslaughter by fake artesunate in Asia-will Africa be next? PLoS Med 2006;3:e197.
40. Ustanso A. RFID technology: A paradigm shift in business process. 35 th International conference on Computers and Industrial engineering, 2005. p. 2065-70.
41. Choi SH, Poon CH. An RFID based anti counterfeiting system IAENG. Int J Comput Sci 2008;35:12.
42. Koroneos G. FDA opens door to RFID packaging. Pharm Technol 2004;28:17. (Pubitemid 39627748)
43. Mehta R. Packaging professional magazine. Biometric fingerprints for anti counterfeiting 2007. Available from: http://www.iom3.org/news/taking- fingerprints [last cited on 2010 Sep 10].
44. Hallie F. Technology advances anti counterfeiting options. Pharmaceutical technology. Packaging Forum 2002. p. 25-31. Available from: www.pharmtech.com [last cited on 2010 Sep 10].
45. Brand protection solutions. World Pharma. World Pharma Frontiers 2010;1:129-35.Available from: http://www.tesa-scribos.com/eng/security- technology [last cited on 2010 Oct 29].
46. Available from: http://www.fujifilm.com/news/n100303.html [last cited on 2010 Jul 15].
47. Osborne P. Anti counterfeiting and track and trace. Pharmaceutical and medical packaging 2007.
48. Carlsbad CA. Delivery system prevents syringe tampering. In the spot light. Pharmaceutical science and technology innovations. Pharmaceutical technology 2003, p. 26. Available from: www.pharmtech.com [last cited on 2010 Sep 10].